Purpose: To determine if measurement of lens protein in serum is a feasible
means to gain information on the physiologic status of the lens in human s
ubjects. Methods: The gamma-crystallin concentration was measured by a sand
wich radioimmunoassay in the sera of 280 subjects aged 25-94 years. Medical
records were reviewed for diagnoses of cataract and aphakia. Results: Ther
e was no effect of age or sex on the serum gamma-crystallin concentration.
There were 57 subjects with cataract and 27 with aphakia. gamma-Crystallin
was higher in all cataract groups and lower in aphakia. The mean gamma-crys
tallin concentrations for selected subject groups were as follows: clear le
ns 301 pg/ml; pure nuclear cataract 344 pg/ml; pure cortical cataract 439 p
g/ml and aphakia 255 pg/ml. Conclusions: This is the first published report
to show that lens protein is measurable in serum and to demonstrate the fe
asibility of using serum assays of lens proteins to gain information on the
physiological status of the lens. Our results confirm the hypothesis that
molecular and cellular events leading to cataract cause increased leakiness
of lens cell membranes with release of lens proteins appearing in the bloo
d. It is conceivable that measurement of lens proteins in serum might find
future use in the evaluation of cataract risk, potentially cataractogenic a
nd anticataractogenic agents, retained lens fragments after phacoemulsifica
tion, secondary cataract, phacolytic glaucoma, anaphylactic endophthalmitis
, eye injuries, and other eye diseases.